Stratos Wealth Partners’s ResMed RMD Stock Holding History

Stratos Wealth Partners’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$385K	Buy	1,716 +361	+27%	+$90K	﹤0.01%	1182
2025 Q4	$327K	Buy	1,355 +59	+5%	+$15.1K	﹤0.01%	1240
2025 Q3	$355K	Buy	1,296 +69	+6%	+$18.8K	﹤0.01%	1170
2025 Q2	$317K	Buy	+1,227	New	+$293K	﹤0.01%	1118
2018 Q4	–	Sell	-167	Closed	-$19K	–	2144
2018 Q3	$19K	Buy	+167	New	+$18.3K	﹤0.01%	1905
2018 Q2	–	Sell	-59	Closed	-$6K	–	2235
2018 Q1	$6K	Buy	59 +8	+16%	+$756	﹤0.01%	2555
2017 Q4	$4K	Buy	+51	New	+$4.21K	﹤0.01%	2464

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Stratos Wealth Partners's RMD Position: Q1 2026 in Review

Stratos Wealth Partners increased its ResMed (RMD) stake by 27% in Q1 2026, buying an estimated $90K and bringing the position to 1,716 shares worth $385K. The position accounts for ﹤0.01% of the portfolio, ranked #1182.

Stratos Wealth Partners first reported a position in RMD in Q4 2017 and has held it in 7 quarters since. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Stratos Wealth Partners held 1,716 shares of ResMed worth $385K as of Q1 2026.
Stratos Wealth Partners bought 361 ResMed shares in Q1 2026, an estimated $90K.
ResMed made up ﹤0.01% of Stratos Wealth Partners's portfolio in Q1 2026, its #1182 holding.
Stratos Wealth Partners first reported a position in ResMed in Q4 2017 and has held it in 7 quarters since.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Stratos Wealth Partners's 13F filing for Q1 2026, filed 28 Apr 2026.